Annual Net Margin
14.49%
+1.26%+9.52%
December 1, 2024
Summary
- As of February 24, 2025, NBIX annual net profit margin is 14.49%, with the most recent change of +1.26% (+9.52%) on December 1, 2024.
- During the last 3 years, NBIX annual net margin has risen by +6.59% (+83.42%).
- NBIX annual net margin is now -70.14% below its all-time high of 48.53%, reached on December 31, 2011.
Performance
NBIX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
16.43%
-4.43%-21.24%
December 1, 2024
Summary
- As of February 24, 2025, NBIX quarterly net profit margin is 16.43%, with the most recent change of -4.43% (-21.24%) on December 1, 2024.
- Over the past year, NBIX quarterly net margin has increased by +8.01% (+95.13%).
- NBIX quarterly net margin is now -78.20% below its all-time high of 75.38%, reached on September 30, 2011.
Performance
NBIX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
NBIX Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.5% | +95.1% |
| 3 y3 years | +83.4% | +95.1% |
| 5 y5 years | +209.0% | +95.1% |
NBIX Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.4% | -42.7% | +190.2% |
| 5 y | 5-year | -62.8% | +209.0% | -42.7% | +173.7% |
| alltime | all time | -70.1% | +100.1% | -78.2% | +100.0% |
Neurocrine Biosciences Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 14.49%(+9.5%) | 16.43%(-21.2%) |
| Sep 2024 | - | 20.86%(+89.5%) |
| Jun 2024 | - | 11.01%(+30.8%) |
| Mar 2024 | - | 8.42%(-70.6%) |
| Dec 2023 | 13.23%(+27.5%) | 28.67%(+72.1%) |
| Sep 2023 | - | 16.66%(-21.0%) |
| Jun 2023 | - | 21.10%(-215.8%) |
| Mar 2023 | - | -18.22%(-184.4%) |
| Dec 2022 | 10.38%(+31.4%) | 21.60%(+22.3%) |
| Sep 2022 | - | 17.66%(-495.1%) |
| Jun 2022 | - | -4.47%(-199.8%) |
| Mar 2022 | - | 4.48%(-291.5%) |
| Dec 2021 | 7.90%(-79.7%) | -2.34%(-130.8%) |
| Sep 2021 | - | 7.60%(-48.1%) |
| Jun 2021 | - | 14.64%(+7.9%) |
| Mar 2021 | - | 13.57%(-160.9%) |
| Dec 2020 | 38.94%(+730.3%) | - |
| Sep 2020 | - | -22.28%(-184.7%) |
| Jun 2020 | - | 26.32%(+66.9%) |
| Mar 2020 | - | 15.77%(+13.2%) |
| Dec 2019 | 4.69%(+0.2%) | 13.93%(-42.5%) |
| Sep 2019 | - | 24.22%(-13.4%) |
| Jun 2019 | - | 27.96%(-137.9%) |
| Mar 2019 | - | -73.77%(-636.9%) |
| Dec 2018 | 4.68%(-105.3%) | 13.74%(-58.9%) |
| Sep 2018 | - | 33.45%(-648.4%) |
| Jun 2018 | - | -6.10%(-89.6%) |
| Mar 2018 | - | -58.83%(-907.0%) |
| Dec 2017 | -88.19%(-90.6%) | 7.29%(-139.8%) |
| Sep 2017 | - | -18.31%(-98.1%) |
| Jun 2017 | - | -946.88%(+637.3%) |
| Dec 2016 | -940.60%(+109.1%) | - |
| Mar 2016 | - | -128.43%(+2029.9%) |
| Dec 2015 | -449.84%(-71.5%) | - |
| Mar 2015 | - | -6.03%(-99.6%) |
| Dec 2013 | -1578.97%(<-9900.0%) | -1457.81%(-4.5%) |
| Sep 2013 | - | -1526.89%(-9.0%) |
| Jun 2013 | - | -1676.99%(+1.4%) |
| Mar 2013 | - | -1654.11%(-3925.4%) |
| Dec 2012 | 9.46%(-80.5%) | 43.24%(-231.4%) |
| Sep 2012 | - | -32.90%(+594.1%) |
| Jun 2012 | - | -4.74%(-39.7%) |
| Mar 2012 | - | -7.86%(-165.6%) |
| Dec 2011 | 48.53%(-304.1%) | 11.98%(-84.1%) |
| Sep 2011 | - | 75.38%(+363.9%) |
| Jun 2011 | - | 16.25%(-29.4%) |
| Mar 2011 | - | 23.03%(+26.5%) |
| Dec 2010 | -23.78%(-98.6%) | 18.21%(-21.1%) |
| Sep 2010 | - | 23.07%(-102.0%) |
| Mar 2010 | - | -1146.88%(+7.2%) |
| Dec 2009 | -1728.34% | -1069.73%(-4.1%) |
| Sep 2009 | - | -1115.55%(-46.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | -2084.58%(-20.8%) |
| Mar 2009 | - | -2632.53%(-33.5%) |
| Dec 2008 | -2229.26%(-86.8%) | -3958.02%(+70.1%) |
| Sep 2008 | - | -2327.33%(-18.5%) |
| Jun 2008 | - | -2857.08%(+137.4%) |
| Mar 2008 | - | -1203.71%(-95.0%) |
| Dec 2007 | -16.94 K%(+6098.1%) | -24.06 K%(+376.9%) |
| Sep 2007 | - | -5044.44%(-90.8%) |
| Jun 2007 | - | -54.92 K%(+122.1%) |
| Mar 2007 | - | -24.73 K%(>+9900.0%) |
| Dec 2006 | -273.25%(+1425.7%) | -155.85%(-95.7%) |
| Sep 2006 | - | -3644.60%(+1127.4%) |
| Jun 2006 | - | -296.94%(+123.3%) |
| Mar 2006 | - | -132.99%(-21.5%) |
| Dec 2005 | -17.91%(-66.7%) | -169.43%(-519.5%) |
| Sep 2005 | - | 40.39%(-339.0%) |
| Jun 2005 | - | -16.90%(-89.4%) |
| Mar 2005 | - | -158.72%(+42.3%) |
| Dec 2004 | -53.74%(+147.1%) | -111.52%(+2247.8%) |
| Sep 2004 | - | -4.75%(-93.6%) |
| Jun 2004 | - | -73.97%(+1.2%) |
| Mar 2004 | - | -73.08%(-720.9%) |
| Dec 2003 | -21.75%(-95.8%) | 11.77%(-135.0%) |
| Sep 2003 | - | -33.61%(+47.8%) |
| Jun 2003 | - | -22.74%(-35.9%) |
| Mar 2003 | - | -35.50%(-96.5%) |
| Dec 2002 | -523.89%(+485.4%) | -1000.18%(+146.3%) |
| Sep 2002 | - | -406.06%(-13.1%) |
| Jun 2002 | - | -467.26%(+46.9%) |
| Mar 2002 | - | -318.01%(+179.3%) |
| Dec 2001 | -89.50%(-54.7%) | -113.85%(-1080.6%) |
| Sep 2001 | - | 11.61%(-102.9%) |
| Jun 2001 | - | -400.96%(+22.0%) |
| Mar 2001 | - | -328.64%(+23.5%) |
| Dec 2000 | -197.48%(+97.5%) | -266.12%(+74.1%) |
| Sep 2000 | - | -152.83%(-13.4%) |
| Jun 2000 | - | -176.48%(-18.9%) |
| Mar 2000 | - | -217.67%(+147.1%) |
| Dec 1999 | -100.00%(-20.0%) | -88.10%(+4.1%) |
| Sep 1999 | - | -84.62%(-29.9%) |
| Jun 1999 | - | -120.73%(+6.0%) |
| Mar 1999 | - | -113.89%(-24.6%) |
| Dec 1998 | -125.00%(-739.7%) | -151.11%(+92.7%) |
| Sep 1998 | - | -78.43%(-77.5%) |
| Jun 1998 | - | -347.83%(+1088.3%) |
| Mar 1998 | - | -29.27%(<-9900.0%) |
| Dec 1997 | 19.54%(-36.4%) | 0.00%(-100.0%) |
| Sep 1997 | - | 12.90%(+520.2%) |
| Jun 1997 | - | 2.08%(-95.5%) |
| Mar 1997 | - | 46.07%(-4.8%) |
| Dec 1996 | 30.73% | 48.39%(-366.2%) |
| Sep 1996 | - | -18.18%(-155.5%) |
| Jun 1996 | - | 32.73% |
FAQ
- What is Neurocrine Biosciences annual net profit margin?
- What is the all time high annual net margin for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual net margin year-on-year change?
- What is Neurocrine Biosciences quarterly net profit margin?
- What is the all time high quarterly net margin for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly net margin year-on-year change?
What is Neurocrine Biosciences annual net profit margin?
The current annual net margin of NBIX is 14.49%
What is the all time high annual net margin for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual net profit margin is 48.53%
What is Neurocrine Biosciences annual net margin year-on-year change?
Over the past year, NBIX annual net profit margin has changed by +1.26% (+9.52%)
What is Neurocrine Biosciences quarterly net profit margin?
The current quarterly net margin of NBIX is 16.43%
What is the all time high quarterly net margin for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly net profit margin is 75.38%
What is Neurocrine Biosciences quarterly net margin year-on-year change?
Over the past year, NBIX quarterly net profit margin has changed by +8.01% (+95.13%)